Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-003038
Filing Date
2016-02-03
Accepted
2016-02-03 16:31:17
Documents
59
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q immu-20151231x10q.htm 10-Q 1425738
2 EX-10.1 immu-20151231ex10160d18c.htm EX-10.1 72888
3 EX-31.1 immu-20151231ex311443a5a.htm EX-31.1 15642
4 EX-31.2 immu-20151231ex3128cb558.htm EX-31.2 16360
5 EX-32.1 immu-20151231ex3213efbf2.htm EX-32.1 12092
  Complete submission text file 0001558370-16-003038.txt   6133966

Data Files

Seq Description Document Type Size
6 EX-101.INS immu-20151231.xml EX-101.INS 1446114
7 EX-101.SCH immu-20151231.xsd EX-101.SCH 38816
8 EX-101.CAL immu-20151231_cal.xml EX-101.CAL 42399
9 EX-101.DEF immu-20151231_def.xml EX-101.DEF 133595
10 EX-101.LAB immu-20151231_lab.xml EX-101.LAB 334286
11 EX-101.PRE immu-20151231_pre.xml EX-101.PRE 277633
Mailing Address 300 AMERICAN ROAD MORRIS PLAINS NJ 07950
Business Address 300 AMERICAN RD MORRIS PLAINS NJ 07950 9736058200
IMMUNOMEDICS INC (Filer) CIK: 0000722830 (see all company filings)

EIN.: 611009366 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-12104 | Film No.: 161385259
SIC: 2835 In Vitro & In Vivo Diagnostic Substances